Insider · CIK 0001657434
Andrew A. F. Hack
director
Files at MRSN (Mersana Therapeutics, Inc.), NUVL (Nuvalent, Inc.). First filing Dec 13, 2024, latest Dec 13, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $110M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 65Notable | Nuvalent, Inc. | $110M 1,250,000 shares | -46% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | MRSN Mersana Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +61,500 | $0.00 | $0 | 61,500 | Jun 13, 2025 |
| Dec 11, 2024 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stockindirect: See footnotes | -1,250,000 | $88.00 | $110M | 1,447,267 | Dec 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.